Glucagon-like peptide 1 (GLP-1) drugs are revolutionising weight management but with more than half of users discontinuing their treatment within months,1 are current drug delivery solutions failing them
It plays a crucial role in numerous life processes, including reproduction, immune system functionality, and cellular differentiation (Bhardwaj et al
The investment in a comprehensive weight loss platform pays dividends through improved health markers, reduced medical expenses, enhanced quality of life, and increased confidence in professional and personal settings
To view a copy of this licence, visit About this article Cite this article Fang, YQ., Ding, H., Li, T
Semaglutide is a glucagon-like peptide-1 (GLP-1) analog that was FDA-approved in 2017 for treatment of type II diabetes and in 2021 for treatment for chronic weight management in adults with obesity or overweight with at least one weight-related condition
An overview on mushroom polysaccharides: health-Promoting properties, prebiotic and gut microbiota modulation effects and structure-function correlation
